195 related articles for article (PubMed ID: 18023103)
1. Correlation of matrix metalloproteinase suppressor genes RECK, VEGF, and CD105 with angiogenesis and biological behavior in esophageal squamous cell carcinoma.
Li SL; Gao DL; Zhao ZH; Liu ZW; Zhao QM; Yu JX; Chen KS; Zhang YH
World J Gastroenterol; 2007 Dec; 13(45):6076-81. PubMed ID: 18023103
[TBL] [Abstract][Full Text] [Related]
2. Endoglin (CD105) is a useful marker for evaluating microvessel density and predicting prognosis in esophageal squamous cell carcinoma.
Sakurai T; Okumura H; Matsumoto M; Uchikado Y; Owaki T; Kita Y; Setoyama T; Omoto I; Kijima Y; Ishigami S; Natsugoe S
Anticancer Res; 2014 Jul; 34(7):3431-8. PubMed ID: 24982351
[TBL] [Abstract][Full Text] [Related]
3. RhoC, vascular endothelial growth factor and microvascular density in esophageal squamous cell carcinoma.
Zhao ZH; Tian Y; Yang JP; Zhou J; Chen KS
World J Gastroenterol; 2015 Jan; 21(3):905-12. PubMed ID: 25624724
[TBL] [Abstract][Full Text] [Related]
4. Expression of vascular endothelial growth factor-C and angiogenesis in esophageal squamous cell carcinoma.
Ding MX; Lin XQ; Fu XY; Zhang N; Li JC
World J Gastroenterol; 2006 Jul; 12(28):4582-5. PubMed ID: 16874878
[TBL] [Abstract][Full Text] [Related]
5. [Relevance of Endoglin (CD105) VEGF and p53 with invasion metastasis and prognosis of laryngeal carcinoma].
Li Q; Zhang B; Peng P
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Dec; 21(24):1114-7. PubMed ID: 18330257
[TBL] [Abstract][Full Text] [Related]
6. Angiogenesis in superficial esophageal squamous cell carcinoma: assessment of microvessel density based on immunostaining for CD34 and CD105.
Kumagai Y; Sobajima J; Higashi M; Ishiguro T; Fukuchi M; Ishibashi K; Baba H; Mochiki E; Yakabi K; Kawano T; Tamaru J; Ishida H
Jpn J Clin Oncol; 2014 Jun; 44(6):526-33. PubMed ID: 24748644
[TBL] [Abstract][Full Text] [Related]
7. [Expression of p53 and vascular endothelial growth factor in esophageal squamous cell carcinoma and their clinical significance].
Liu DB; Chen KN; Cao XZ; Wang T
Ai Zheng; 2002 Sep; 21(9):989-93. PubMed ID: 12508548
[TBL] [Abstract][Full Text] [Related]
8. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
Kato H; Yoshikawa M; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Tsukada K; Kuwano H
Anticancer Res; 2002; 22(6C):3977-84. PubMed ID: 12553021
[TBL] [Abstract][Full Text] [Related]
9. Expression of PC cell-derived growth factor and vascular endothelial growth factor in esophageal squamous cell carcinoma and their clinicopathologic significance.
Chen XY; Li JS; Liang QP; He DZ; Zhao J
Chin Med J (Engl); 2008 May; 121(10):881-6. PubMed ID: 18706200
[TBL] [Abstract][Full Text] [Related]
10. Thymidine phosphorylase and angiogenesis in early stage esophageal squamous cell carcinoma.
Kumagai Y; Tachikawa T; Higashi M; Sobajima J; Takahashi A; Amano K; Fukuchi M; Ishibashi KI; Mochiki E; Yakabi K; Tamaru JI; Ishida H
Esophagus; 2018 Jan; 15(1):19-26. PubMed ID: 29892805
[TBL] [Abstract][Full Text] [Related]
11. [Expression and clinical significance of VEGF-C mRNA and CD 31 in esophageal squamous cell carcinoma].
Ding MX; Li JC
Shi Yan Sheng Wu Xue Bao; 2003 Aug; 36(4):269-74. PubMed ID: 14574989
[TBL] [Abstract][Full Text] [Related]
12. The expression of LC-3 is related to tumor suppression through angiogenesis in esophageal cancer.
Sakurai T; Okumura H; Matsumoto M; Uchikado Y; Setoyama T; Omoto I; Owaki T; Maemura K; Ishigami S; Natsugoe S
Med Oncol; 2013 Dec; 30(4):701. PubMed ID: 24122254
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta binding receptor endoglin (CD105) expression in esophageal cancer and in adjacent nontumorous esophagus as prognostic predictor of recurrence.
Bellone G; Solerio D; Chiusa L; Brondino G; Carbone A; Prati A; Scirelli T; Camandona M; Palestro G; Dei Poli M
Ann Surg Oncol; 2007 Nov; 14(11):3232-42. PubMed ID: 17682823
[TBL] [Abstract][Full Text] [Related]
14. The onset of angiogenesis in a multistep process of esophageal squamous cell carcinoma.
Kubota Y; Kaneko K; Konishi K; Ito H; Yamamoto T; Katagiri A; Muramoto T; Yano Y; Kobayashi Y; Oyama T; Kushima M; Imawari M
Front Biosci (Landmark Ed); 2009 Jan; 14(10):3872-8. PubMed ID: 19273317
[TBL] [Abstract][Full Text] [Related]
15. [Relationship between CD105 and angiogenesis and biological behaviors in squamous carcinoma of larynx].
Gu X; Xu Y; Wu H; Xu X
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Feb; 20(3):125-8. PubMed ID: 16646406
[TBL] [Abstract][Full Text] [Related]
16. Extracellular matrix metalloproteinase inducer (EMMPRIN) expression correlates positively with active angiogenesis and negatively with basic fibroblast growth factor expression in epithelial ovarian cancer.
Szubert S; Szpurek D; Moszynski R; Nowicki M; Frankowski A; Sajdak S; Michalak S
J Cancer Res Clin Oncol; 2014 Mar; 140(3):361-9. PubMed ID: 24374756
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic significance of CD105 expression in squamous cell carcinoma of the hypopharynx.
Chien CY; Su CY; Hwang CF; Chuang HC; Hsiao YC; Wu SL; Huang CC
Head Neck; 2006 May; 28(5):441-6. PubMed ID: 16320363
[TBL] [Abstract][Full Text] [Related]
18. Correlation between CD105 expression and postoperative recurrence and metastasis of hepatocellular carcinoma.
Yang LY; Lu WQ; Huang GW; Wang W
BMC Cancer; 2006 May; 6():110. PubMed ID: 16650286
[TBL] [Abstract][Full Text] [Related]
19. Coexpression of vascular endothelial growth factor and p53 protein in squamous cell carcinoma of the esophagus.
Koide N; Nishio A; Hiraguri M; Hanazaki K; Adachi W; Amano J
Am J Gastroenterol; 2001 Jun; 96(6):1733-40. PubMed ID: 11419822
[TBL] [Abstract][Full Text] [Related]
20. Endoglin (CD105) expression in angiogenesis of primary hepatocellular carcinomas: analysis using tissue microarrays and comparisons with CD34 and VEGF.
Yao Y; Pan Y; Chen J; Sun X; Qiu Y; Ding Y
Ann Clin Lab Sci; 2007; 37(1):39-48. PubMed ID: 17311868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
